For Kapstone Medical
Part 4 in our 7-part series on meeting the new requirements under the EU MDR
Complying with the European Union’s Medical Device Regulation (MDR) poses a daunting task for medical device makers marketing products inside the EU. One of the most taxing efforts for companies that already have CE-marked devices in the EU is the need for portfolio reviews. (published site)
For Advanced Orthopedics
Patients who underwent Posterior Cervical Fusion (PCF) and decompression obtained significant clinical improvement with high fusion rates and low revision and complication rates, and patient reported outcomes matched and, in some cases, exceeded the clinical results, according to a new study. (published site)
Faced with performance-based reimbursement and growing pressure for improving outcomes, physicians are looking for ways to improve their patient communications and education in order to engage them and activate them for better health. (published site)
Part 3 in our 7-part series on meeting the new requirements under the EU MDR
If you are new to obtaining marketing approval in the European Union, the concept of Notified Bodies is one of the most significant differences from the US FDA system or regulatory oversight.
A Notified Body is an independent certification organization that is “notified” by an EU member state’s Competent Authority, usually the ministry of health, to certify that a product meets the applicable requirements for CE marking.
For Kapstone Medical
High level areas to consider
Second in a 7-part series on the EU’s Medical Device Regulation
The new Medical Devices Regulation (2017/745/EU), or more commonly referred to as the EU MDR, poses significant challenges to medical device makers that want to market their products in the European Union. (published site)
